NO145839C - Analogifremgangsmaate for fremstilling av hypolipidemiske p-aminobenzoesyrer - Google Patents

Analogifremgangsmaate for fremstilling av hypolipidemiske p-aminobenzoesyrer

Info

Publication number
NO145839C
NO145839C NO770151A NO770151A NO145839C NO 145839 C NO145839 C NO 145839C NO 770151 A NO770151 A NO 770151A NO 770151 A NO770151 A NO 770151A NO 145839 C NO145839 C NO 145839C
Authority
NO
Norway
Prior art keywords
aminobenoic
hypolipidemic
acids
preparation
analogy procedure
Prior art date
Application number
NO770151A
Other languages
English (en)
Norwegian (no)
Other versions
NO770151L (no
NO145839B (no
Inventor
Eugene Ross Wagner
Bobbie Jewel Allen
Alfred Arthur Renzi
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of NO770151L publication Critical patent/NO770151L/no
Publication of NO145839B publication Critical patent/NO145839B/no
Publication of NO145839C publication Critical patent/NO145839C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO770151A 1976-01-19 1977-01-18 Analogifremgangsmaate for fremstilling av hypolipidemiske p-aminobenzoesyrer NO145839C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65009076A 1976-01-19 1976-01-19

Publications (3)

Publication Number Publication Date
NO770151L NO770151L (no) 1977-07-20
NO145839B NO145839B (no) 1982-03-01
NO145839C true NO145839C (no) 1982-06-09

Family

ID=24607411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770151A NO145839C (no) 1976-01-19 1977-01-18 Analogifremgangsmaate for fremstilling av hypolipidemiske p-aminobenzoesyrer

Country Status (14)

Country Link
JP (1) JPS5289660A (en:Method)
AT (1) AT347923B (en:Method)
AU (1) AU500881B2 (en:Method)
BE (1) BE850516A (en:Method)
CA (1) CA1072969A (en:Method)
CH (1) CH628340A5 (en:Method)
DE (1) DE2702058C2 (en:Method)
DK (1) DK153471C (en:Method)
FR (1) FR2338040A1 (en:Method)
GB (2) GB1521458A (en:Method)
IE (1) IE44858B1 (en:Method)
NL (1) NL7700480A (en:Method)
NO (1) NO145839C (en:Method)
SE (1) SE435175B (en:Method)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE716668C (de) * 1938-02-15 1942-01-27 Dr Aladar Skita Verfahren zur Herstellung von Derivaten substituierter Aminobenzoesaeuren
FR2080069A5 (en:Method) * 1970-02-23 1971-11-12 Commissariat Energie Atomique
US3868416A (en) * 1973-10-01 1975-02-25 American Cyanamid Co Hypolipidemic 4-(monoalkylamino)benzoic acid derivatives

Also Published As

Publication number Publication date
GB1521459A (en) 1978-08-16
BE850516A (fr) 1977-07-19
DK153471B (da) 1988-07-18
NL7700480A (nl) 1977-07-21
NO770151L (no) 1977-07-20
IE44858L (en) 1977-07-19
AU500881B2 (en) 1979-06-07
FR2338040B1 (en:Method) 1980-04-30
DE2702058A1 (de) 1977-07-28
IE44858B1 (en) 1982-04-21
GB1521458A (en) 1978-08-16
AU2114077A (en) 1978-07-13
DK8177A (da) 1977-07-20
SE7700490L (sv) 1977-07-20
AT347923B (de) 1979-01-25
FR2338040A1 (fr) 1977-08-12
SE435175B (sv) 1984-09-10
CH628340A5 (en) 1982-02-26
JPS5289660A (en) 1977-07-27
ATA31277A (de) 1978-06-15
NO145839B (no) 1982-03-01
CA1072969A (en) 1980-03-04
JPS6233230B2 (en:Method) 1987-07-20
DK153471C (da) 1988-11-21
DE2702058C2 (de) 1985-09-19

Similar Documents

Publication Publication Date Title
NO145881C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme acetohydroksamsyrer
DK59077A (da) Fremgangsmade til fremstilling af hidtil ukendte carboxyalkylacylaminosyrer
NO791324L (no) Fremgangsmaate til polymerisering av alkener
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
SE7705886L (sv) Forfarande for framstellning av fosfonsyror
SE7714349L (sv) Forfarande for framstellning av hydroxamsyror
DK206677A (da) Fremgangsmade til fremstilling af 12-azaprostansyrer
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
DK19677A (da) Fremgangsmade til fremstilling af hypolipidemiske p-benzylaminobenzoesyrer
DK156661C (da) Analogifremgangsmaade til fremstilling af 1-azaxanton-3-karboxylsyrer
DK470376A (da) Fremgangsmade til fremstilling af phenoxyalcarboxylsyrer
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
SE7703628L (sv) Forfarande for framstellning av resoler
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE7707621L (sv) Forfarande for framstellning av xyloslosning
DK153176A (da) Fremgangsmade til fremstilling af fenylpropionsyrer
SE416469B (sv) Forfarande for framstellning av aralkansyror innehallande dihydrofuran - eller dihydropyranringar
SE7601151L (sv) Forfarande for framstellning av cefemkarboxylsyror
DK247976A (da) Fremgangsmade til fremstilling af quinolin-3-carboxylsyrer
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE418395B (sv) Forfarande for framstellning av indanettiksyror
NO149875C (no) Fremgangsmaate for fremstilling av insulin
NO772237L (no) Fremgangsm}te for fremstilling av n-benzylaminosyrer
PL201522A1 (pl) Sposob otrzymywania kwasow aristolochialowych